0930 ET - Humana tells analysts on its 1Q call that medical costs are running in line with its expectations and the impact of federal billing rule changes is also playing out as predicted. The company says it had no update on its closely-watched litigation aimed at fixing a huge expected decline in quality-related Medicare bonuses. Humana said it is still aiming to achieve a 3% margin on its core business in 2027. Humana is up 6% in early trading. (anna.mathews@wsj.com)
(END) Dow Jones Newswires
April 30, 2025 09:30 ET (13:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。